K. Drucis
发表论文 35 篇 · 总被引 3087 次 · h-index 10
代表论文
- Improved overall survival in melanoma with combined dabrafenib and trametinib. (2015 · New England Journal of Medicine · 被引 2458)
- Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial. (2015 · The Lancet Oncology · 被引 227)
- MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial. (2018 · The Lancet Oncology · 被引 155)
- Three-year estimate of overall survival in COMBI-v, a randomized phase 3 study evaluating first-line dabrafenib (D) + trametinib (T) in patients (pts) with unresectable or metastatic BRAF V600E/K–mutant cutaneous melanoma (2016 · 被引 72)
- Simultaneous Determination of Na+, K+, Ca2+, Mg2+ and Cl− in Unstimulated and Stimulated Human Saliva Using All Solid State Multisensor Platform (2017 · 被引 27)
- Nonlinear Modeling with Mammographic Evidence of Carcinoma (2010 · 被引 18)